Intimation for receiving the possession of manufacturing facility

Date: 21st October, 2026 To, To, The Manager (Listing) Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, G Block, Dalal Street, Fort, Mumbai - 400 001 Bandra-Kurla Complex, BSE Symbol: ANUHPHR Bandra (E), Mumbai – 400051 BSE Scrip Code: 506260 NSE Symbol: ANUHPHR; Series: EQ Sub: Disclosure under Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015) in respect of receiving possession of the manufacturing facility. Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), and further to our intimation dated 16th October, 2026, we wish to inform you that Anuh Pharma Limited (“APL”) has received the possession of manufacturing facility of M/s. Vanquest Pharma Private Limited (“VPPL”) located at F-10, M.I.D.C., Tarapur, Boisar, District Palghar – 401506, Maharashtra, India pursuant to the Asset Transfer Agreement (“ATA”) executed on 16th October, 2026. We further confirm that there are no material changes to the details of the transaction as disclosed in our initial intimation dated 16th October, 2026. The above information is also available on the website of the Company www.anuhpharma.com. You are requested to kindly take the same on record. Thanking you, Yours faithfully, FOR ANUH PHARMA LIMITED MANAN VADHAN COMPANY SECRETARY & COMPLIANCE OFFICER Place: Mumbai